[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100174962":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":37,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Helse Stavanger HF","OTHER_GOV",null,[9],{"name":10,"affiliation":5,"role":11},"Tore Grimstad, PhD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":14,"role":15,"phone":7,"phoneExt":7,"email":16},"tore grimstad","CONTACT","tore.bjorn.grimstad@sus.no",{"name":18,"role":15,"phone":7,"phoneExt":7,"email":19},"lars aabakken","larsaa@medisin.uio.no",[21],{"facility":22,"status":23,"city":24,"state":7,"zip":7,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"SUS","RECRUITING","Stavanger","Norway","NO",{"type":28,"coordinates":29},"Point",[30,31],5.73332,58.97005,{"lat":31,"lon":30},[34],{"name":35,"role":15,"phone":36,"phoneExt":7,"email":7},"Tore B Grimstad, MD PhD","+47909 21 650",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100174962","stavanger-university-hospital-inflammatory-bowel-disease-trial-100174962",false,"NCT01551563","Stavanger University Hospital Inflammatory Bowel Disease Trial","Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue","SUSI","Inclusion Criteria:\n\n* newly diagnosed IBD\n\nExclusion Criteria:\n\n* previous IBD with specific treatment within 10 year\n* inability to consent\n* inability to adhere to treatment protocol","ALL","16 Years","80 Years",{"count":51,"type":52},700,"ESTIMATED","OBSERVATIONAL","The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.\n\nCytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.",[56],"IBD","2025-05-13",{"date":59,"type":60},"2025-05-16","ACTUAL",{"date":62,"type":7},"2012-04",{"date":64,"type":52},"2030-12",{"name":5,"class":6},1]